Streetbeat News

Analyst Ratings

MTD

Mettler-Toledo Intl (NYSE:MTD) has received 4 analyst ratings in the last quarter, with an average 12-month price target of $1175.0, a decrease from the previous target of $1357.50. The ratings include 1 bullish, 1 somewhat bullish, and 2 indifferent. No bearish ratings were reported. The high price target is $1300.00 and the low is $1030.00.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 6:00 pm

ESPR

Esperion Therapeutics (NASDAQ:ESPR) has received 4 bullish analyst ratings in the last quarter with an average price target of $15.25, indicating a significant upside from the current price of $0.9199. The average price target has risen by 69.44% over the past month, suggesting a positive outlook from analysts on the stock.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 6:00 pm

OSK

Oshkosh (NYSE:OSK) has received 5 analyst ratings in the last quarter, with 3 bullish, 1 somewhat bullish, and 1 indifferent. No bearish ratings were reported. The average price target for OSK is $114.2, representing an upside from the current price of $94.31. The target has increased by 2.27% over the past month. Analysts typically review stocks quarterly or after major company updates, basing their ratings on financial predictions and company risk profiles.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 6:00 pm

HD

LOW

M

TGT

WMT

Home Depot Inc (HD) is set to report Q3 earnings on Nov. 14, with analysts expecting $3.58 EPS and $35.66 billion in revenue. The company has beaten EPS estimates for the past 12 quarters. Analysts are cautious due to higher interest rates, inflation, and a shift in consumer spending. Stifel analyst expects a 3% decline in FY23 comparable sales for Home Depot. The consensus price target is $319.23, with an average Buy rating. Stifel has a Hold rating with a target price of $306. HD stock traded at $288.54 and is down 8.5% YTD. Other retailers like Lowe's (LOW), Target (TGT), Walmart (WMT), and Macy's (M) are also reporting earnings this week.

Portfolio Pulse from Surbhi Jain

November 13, 2023 | 5:58 pm

GTLB

GitLab shares are trading higher following BTIG's initiation of coverage on the stock with a Buy rating and a $56 price target.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:57 pm

GH

Guardant Health's stock (GH) is trading higher following an upgrade from Raymond James, changing its rating from Market Perform to Outperform.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:56 pm

CRSP

CRISPR Therapeutics AG (NASDAQ:CRSP) stock is trading higher despite Morgan Stanley maintaining an Underweight rating and lowering the price target from $43 to $42. RBC Capital and Needham also lowered their price targets, but Needham maintains a Buy rating. CRISPR reported Q3 losses better than expected, and the stock is trending among retail investors and short-sellers, with a high short interest of 17.72%.

Portfolio Pulse from Erica Kollmann

November 13, 2023 | 5:45 pm

PX

Oppenheimer analyst Chris Kotowski has reiterated an Outperform rating on P10, which trades under the ticker PX on the NYSE, and has maintained a price target of $15 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:45 pm

NTRA

Natera, Inc. (NTRA) shares have risen following an upgrade by Raymond James from Outperform to Strong Buy, indicating a positive outlook on the stock by the firm.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:44 pm

MPWR

Oppenheimer analyst Rick Schafer has maintained an Outperform rating on Monolithic Power Systems (NASDAQ:MPWR) and increased the price target from $500 to $600.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:43 pm